CorVel Corp logo

CorVel Corp(CRVL)

upturn advisory logo
EXPLORE ADVISORIES AND THEIR HISTORY
QUALITY SIGNAL RECENCY
2-STAR RATING
Consider higher Upturn Star rating
BUY for 149 days
PROFIT SINCE LAST BUY
+53.8% ▲
LAST CLOSE
$88.28
11/20/2026
(24-hour delay)

Advisory History & Simulated Performance *

*as per simulation (see disclosures)
  • ALL
  • 1Y
  • 1M
  • 1W
  • BUY Advisory
  • SELL Advisory (Profit)
  • SELL Advisory (Loss)
  • Profit
  • Loss
  • PASS (Skip)
Upturn Stock price based on last close iconStock price based on last close
Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Advisory Performance History (Simulated)Advisory Performance History info

Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Upturn Advisory & Investor View for CRVL

11/20/2026: CRVL (2-star) has a low Upturn Star Rating. Not recommended to BUY.

CorVel Corp is a technology-driven provider of healthcare cost containment, network solutions, and claims management services primarily focused on the workers' compensation market. The company's primary business strength lies in its proprietary CareMC software platform, which delivers stable, high-margin transaction fee revenue without direct insurance underwriting risk. Its primary growth opportunity stems from the ongoing integration of artificial intelligence tools like CogencyIQ to optimize episode workflows. Key risks include intense competitive pressures within the administrative services sector and vulnerability to domestic employment cycles. The stock is best suited for growth-oriented and fundamental investors seeking exposure to healthcare efficiency solutions while monitoring regulatory changes and small-cap liquidity.

How to Read the Upturn Advisory

The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.

Company fundamentals, valuation, risks, and news provide supporting context about the business.

Investor Fit

Investor styleFitWhy
Growth investorMixed fitCorVel delivers steady, dependable top-line expansion rather than hyper-growth characteristics.
Momentum investorStrong fit while signal remains positiveThe stock can appeal to momentum strategies during periods of strong relative outperformance and positive technical breakouts.
Value investorMixed fitStable earnings and clean balance sheet appeal to fundamental investors, though valuation multiples can sometimes look elevated relative to traditional insurers.
Dividend investorWeak fitCorVel does not currently pay a regular cash dividend, prioritizing capital reinvestment and share buybacks instead.
Low-risk investorMixed fitWhile the balance sheet is exceptionally sound with minimal debt, smaller-cap market liquidity and price fluctuations can introduce moderate volatility.

Risk Profile

Risk factorLevelWhy it matters
Price volatilityMediumThe stock experiences moderate price fluctuations typical of small-to-mid cap equities.
Valuation riskMediumPrice-to-earnings multiples can occasionally stretch during periods of strong market sentiment.
Competition risk (TPA and healthcare tech software competition)Medium / highIntense competition from larger alternative TPAs and emerging tech platforms pressures margins.
Business qualityStrongThe company features high cash conversion, low leverage, and a resilient fee-based business model.
Dividend incomeLow / noneIncome-focused investors receive no regular dividend distributions from the stock.
Execution riskMediumSustaining technology updates and navigating healthcare regulatory shifts successfully requires precise management execution.

Key Highlights

Company Size Mid-Cap Stock
Market Capitalization 4.40B USD
Price to earnings Ratio 36.71
1Y Target Price -
Price to earnings Ratio 36.71
1Y Target Price -
Volume (30-day avg) 185.7K shares
Beta 1.08
52 Weeks Range 44.83 - 90.71
Updated Date 11/19/2026
52 Weeks Range 44.83 - 90.71
Updated Date 11/19/2026
Dividends yield (FY) -
Basic EPS (TTM) 2.38

Sector & Industry Intelligence

Sector

Financial Services

Caution
Sentiment
Weak Bullish
Momentum
BUY Breadth Lower
BUY participation
30.8%
Active BUY / eligible
28 / 91
30-Day BUY Count Change
+13
Market state
Weak Bullish

Qualifying BUY stocks have fallen well below recent levels and have not recovered.

Industry

Insurance Brokers

BUY participation
50.0%
Active BUY / eligible
1 / 2
30-Day BUY Count Change
+1

Eligible universe: 2 stocks.

Sector signal summarizes BUY breadth conditions for the sector. It does not override this stock’s BUY, SELL, or PASS advisory.

Price Behavior

Hockey-Stick Growth
PRICE PATH

Hockey-Stick Growth

The stock demonstrates a Hockey-Stick Growth price path pattern.

Smooth
PRICE STABILITY

Smooth

The stock has moved along a generally orderly path with only modest fluctuations.

Analysis of Past Performance

Type Stock
Historic Profit 10.24%
Avg. Invested days 39
Today’s Advisory Consider higher Upturn Star rating
Upturn Advisory Rating upturn star rating icon
Upturn Advisory Performance Upturn Advisory Performance icon 2.0
Stock Returns Performance Upturn Returns Performance icon 2.0
Upturn Profits based on simulation icon Profits based on simulation
Upturn last close icon Last Close 11/20/2026

Upturn Scorecard

Upturn Star Rating

★★★★★
CRVL receives a 3-star rating, supported by solid company fundamentals. The rating is constrained by soft analyst coverage, and weak price momentum.

Company Fundamentals

★★★★★
CRVL has solid overall fundamentals (4 stars), with solid financial health, solid growth momentum, and solid ownership. In FY2026 versus FY2025, solid earnings growth (+16.0%) and solid cash generation (FCF margin 11.5%) are partially offset by moderate revenue growth (+7.0%).

Financial Health Rating

★★★★★
CRVL's financial health is supported by solid liquidity, including working-capital and asset support (WC/assets 36.4%). Profitability is moderate (3 stars), which helps explain the 4-star overall score.

Growth Momentum Score

★★★★★
Free-cash-flow growth is CRVL's strongest growth driver at +20.4% FY2026 versus FY2025 (solid, 4 stars). Revenue growth (+7.0%, moderate) and earnings growth (+16.0%, solid) are also constructive, though not equally high across every growth measure.

Ownership

★★★★★
Institutional ownership is 56.5% and approximately 61.0% of outstanding shares are publicly tradable, supporting liquidity and institutional participation. Insider ownership of 39.01% supports management-shareholder alignment.

Top 5 Institutional Investors

BlackRock Inc 10.20%
Kayne Anderson Rudnick Investment Management LLC 9.03%
Vanguard Portfolio Management, LLC 3.41%
Renaissance Technologies Corp 2.87%
Vanguard Capital Management, LLC 2.58%

Unit Economics (Per $1K Revenue)

★★★★★
CRVL generates approximately $243 of gross profit, $149 of operating income, and $115 of free cash flow for every $1,000 of revenue. Based on FY2026 results. Moderate margins and solid cash conversion support a 3-star rating, while capital efficiency is strong.

Economic Dimensions

★★★★★
Effective Tax Rate: 22.91%

Quantitative Style Profile

★★★★★
CRVL has a high-quality, liquid profile. Weak momentum is the primary drawback, while valuation that is moderately attractive rather than deeply discounted.

Style Classification

Quality Focused

Quality TiltSmall / Mid Cap RiskShort Squeeze RiskHighly Liquid / Institution-Friendly

How Company Makes Money

Business areaWhat it includesRetail investor read
Network SolutionsMedical bill review, PPO network access fees, pharmacy benefit management, and repricing services.CorVel collects transaction and percentage-based fees every time medical bills are processed and discounted for insurers.
Patient ManagementClaims administration, case management, nurse triage, and vocational rehabilitation services.The company earns service revenue by managing workplace injury claims from inception to resolution on behalf of employers.

Analyzing Revenue: Products, Geography and Growth

Revenue by Products

Product revenue - Year on Year

Earnings Date

Report Date 2026-11-03
When Before Market
Estimate -
Actual 0.67

Profitability

Profit Margin 12.02%
Operating Margin (TTM) 15.94%

Management Effectiveness

Return on Assets (TTM) 15.2%
Return on Equity (TTM) 30.64%

Valuation

Trailing PE 36.71
Forward PE 23.75
Enterprise Value 4.24B
Price to Sales(TTM) 4.35
Enterprise Value 4.24B
Price to Sales(TTM) 4.35
Enterprise Value to Revenue 4.19
Enterprise Value to EBITDA 21.69
Shares Outstanding 50.35M
Shares Floating 30.70M
Shares Outstanding 50.35M
Shares Floating 30.70M
Percent Insiders 39.01
Percent Institutions 56.46

Financial Metrics

🧭 Investment Snapshot

Total Revenue (Scale)

Information icon Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.

Net Income (Profit)

Information icon Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.

Free Cash Flow (Cash Strength)

Information icon Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.

📈 Growth & Strength

Operating Income (Core Profit)

Information icon Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.

EBITDA (Cash Earnings)

Information icon Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.

Gross Profit (Unit Profitability)

Information icon Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.

🛡️ Financial Safety

Cash (Liquidity Buffer)

Information icon Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.

Total Debt (Leverage Risk)

Information icon Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.

Net Working Capital (Short-Term Health)

Information icon Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.

🧱 Balance Sheet Strength

Stockholder Equity (Net Worth)

Information icon Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.

Total Assets (Asset Base)

Information icon The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.

Income Before Tax (Pre-Tax Earnings)

Information icon Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.

⚙️ Cost & Drag Factors

Cost of Revenue (Production Cost)

Information icon Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.

Total Operating Expenses (Operating Cost)

Information icon Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.

Income Tax Expense (Tax Drag)

Information icon Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.

Form CRS provides a relationship summary of our automated advisory services, flat subscription fees, and conflicts of interest. Form ADV Part 2A brochure contains complete details on services, billing, and disclosures. If any summary differs from our current regulatory filings, the filed Form ADV controls.